Dermatol. praxi. 2020;14(2):63-70 | DOI: 10.36290/der.2020.011

Treatment of psoriasis

MUDr. Jorga Fialová1,2, MUDr. Martina Kojanová, Ph.D.1
1 Dermatovenerologická klinika VFN a 1. LF UK, Praha
2 Dermatovenerologická ambulance, Nemocnice Milosrdných sester sv. Karla Boromejského, Praha

Psoriasis is a chronic inflammatory immune-mediated systemic disease. The therapeutic options depend on many factors. In recent years, systemic treatment of psoriasis has made significant progress. In order to optimize and individualize the treatment, the guidelines have been developed. Despite their regular updates, new scientific knowledge and up-to-date guidance should be followed.

Keywords: psorias, systemic therapy, biological therapy, small-molecule therapy.

Published: June 18, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fialová J, Kojanová M. Treatment of psoriasis. Dermatol. praxi. 2020;14(2):63-70. doi: 10.36290/der.2020.011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kojanová M, Fialová J, Cetkovská P, Gkalpakiotis S, Jirčíková J, Doležal T, Arenberger P; BIOREP study group. Analýza pacientů se středně těžkou až těžkou psoriázou před zahájením biologické léčby v České republice - Údaje z registru BIOREP 2005-2016. Čes‑slov Derm 2016; 91(5): 223-232.
    2. Kojanová M, Fialová J, Cetkovská P, Gkalpakiotis S, Jirčíková J, Doležal T, Arenberger P; BIOREP study group. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries. Int J Dermatol, 2017; 56: 428-434. Go to original source...
    3. Cetkovská P, Kojanová M, Arenberger P, Fabiánová J. Přehled současných doporučených postupů pro systémovou "nebiologickou" léčbu psoriázy. Čes‑slov Derm 2017; 92(1): 3-17.
    4. Státní ústav pro kontrolu léčiv, dostupné 6. 1. 2020: http://www.sukl.cz/modules/medication/search.php
    5. Cetkovská P, Kojanová M, Arenberger P, Fabiánová J. Současný stav moderní léčby psoriázy - aktualizovaná doporučení ČDS JEP k cílené léčbě závažné chronické psoriázy. Čes‑slov Derm 2019; 94(4): 135-164.
    6. Menter A, et al. Guidelines of care for the management of psoriasis and psoraitic arthritis. Section 3. Guidelines of care fot the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009; 60(4): 643-659. Go to original source...
    7. Fialová J. Psoriáza. Postgraduální medicína 2010; 12(4): 43-50.
    8. Viktorínová M. Přehled lokálních kortikosteroidů v dermatologii 2. Klin Farmakol, Farm. 2007; 21: 36-41.
    9. Ditrichová D. Ichtamol a dehty v současné dermatologické terapii. Klin Farmakol, Farm. 2005; 19: 47-48.
    10. Fadrhoncová, A. Farmakoterapie kožních nemocí. Praha: Grada Publishing 1999, 416 s.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.